| 1 |
33898880 | Mn-containing bioceramics inhibit osteoclastogenesis and promote osteoporotic bone regeneration via scavenging ROS. | 2021 Nov |
2 |
| 2 |
34136493 | Oxymatrine Attenuates Osteoclastogenesis via Modulation of ROS-Mediated SREBP2 Signaling and Counteracts Ovariectomy-Induced Osteoporosis. | 2021 |
2 |
| 3 |
34650437 | Nox4 Promotes RANKL-Induced Autophagy and Osteoclastogenesis via Activating ROS/PERK/eIF-2α/ATF4 Pathway. | 2021 |
5 |
| 4 |
31724123 | RANKL treatment of vascular endothelial cells leading to paracrine pro-calcific signaling involves ROS production. | 2020 Jan |
5 |
| 5 |
32075617 | Polyphyllin VII attenuated RANKL-induced osteoclast differentiation via inhibiting of TRAF6/c-Src/PI3K pathway and ROS production. | 2020 Feb 19 |
2 |
| 6 |
32485573 | GSH attenuates RANKL-induced osteoclast formation in vitro and LPS-induced bone loss in vivo. | 2020 Aug |
6 |
| 7 |
32899248 | Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling. | 2020 Sep 3 |
9 |
| 8 |
32976685 | Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway. | 2020 Nov |
2 |
| 9 |
30732873 | Cerium ion promotes the osteoclastogenesis through the induction of reactive oxygen species. | 2019 Mar |
1 |
| 10 |
30826055 | CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response. | 2019 Apr 9 |
5 |
| 11 |
31496878 | Humanin suppresses receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation via AMP-activated protein kinase activation. | 2019 Sep |
1 |
| 12 |
28302039 | Bone Degeneration, Inflammation and Secondary Complications of Arthritis: Potential Targets and their Natural Inhibitors. | 2018 |
1 |
| 13 |
29342179 | The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors. | 2018 |
1 |
| 14 |
29378912 | Endoplasmic Reticulum-Bound Transcription Factor CREBH Stimulates RANKL-Induced Osteoclastogenesis. | 2018 Mar 1 |
2 |
| 15 |
30483128 | Effects of Taxifolin on Osteoclastogenesis in vitro and in vivo. | 2018 |
2 |
| 16 |
28088947 | Heme oxygenase-1 (HO-1)/carbon monoxide (CO) axis suppresses RANKL-induced osteoclastic differentiation by inhibiting redox-sensitive NF-κB activation. | 2017 Feb |
1 |
| 17 |
29145718 | Lipopolysaccharide (LPS)-Induced Autophagy Is Responsible for Enhanced Osteoclastogenesis. | 2017 Nov 30 |
2 |
| 18 |
26795736 | Molecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymes. | 2016 Aug |
4 |
| 19 |
26962001 | HDAC2 regulates FoxO1 during RANKL-induced osteoclastogenesis. | 2016 May 15 |
1 |
| 20 |
27515196 | Epstein-Barr virus infection induces bone resorption in apical periodontitis via increased production of reactive oxygen species. | 2016 Sep |
1 |
| 21 |
25466887 | Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss. | 2015 Mar |
2 |
| 22 |
26442864 | NRROS Negatively Regulates Osteoclast Differentiation by Inhibiting RANKL-Mediated NF-N:B and Reactive Oxygen Species Pathways. | 2015 Oct |
2 |
| 23 |
24959146 | Osteoporosis and alzheimer pathology: Role of cellular stress response and hormetic redox signaling in aging and bone remodeling. | 2014 |
2 |
| 24 |
25397470 | HIV-1 tat and rev upregulates osteoclast bone resorption. | 2014 |
3 |
| 25 |
23538677 | Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes. | 2013 |
4 |
| 26 |
22449704 | Glutaredoxin2 isoform b (Glrx2b) promotes RANKL-induced osteoclastogenesis through activation of the p38-MAPK signaling pathway. | 2012 Mar |
2 |
| 27 |
22525805 | Platinum nanoparticles reduce ovariectomy-induced bone loss by decreasing osteoclastogenesis. | 2012 Jul 31 |
1 |
| 28 |
21071867 | Gold nanoparticles inhibited the receptor activator of nuclear factor-κb ligand (RANKL)-induced osteoclast formation by acting as an antioxidant. | 2010 |
2 |
| 29 |
19725047 | Oxidized low density lipoprotein decreases Rankl-induced differentiation of osteoclasts by inhibition of Rankl signaling. | 2009 Dec |
1 |
| 30 |
18305398 | Rutin inhibits osteoclast formation by decreasing reactive oxygen species and TNF-alpha by inhibiting activation of NF-kappaB. | 2008 Feb 29 |
1 |
| 31 |
16632109 | Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. | 2006 May 1 |
6 |
| 32 |
15731115 | Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. | 2005 Apr 29 |
9 |
| 33 |
15817678 | A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. | 2005 Aug 1 |
7 |
| 34 |
15972689 | TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells. | 2005 Jul 1 |
1 |
| 35 |
15530848 | Reactive oxygen species mediate RANK signaling in osteoclasts. | 2004 Dec 10 |
2 |